https://www.indianpharmapost.com/dr-reddys-and-senores-pharmaceuticals-launches-ketorolac-tromethamine-tablets-in-the-us-market-123252022-05-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/johnson-johnson-and-momenta-pharmaceuticals-file-lawsuit-against-natco-pharma-123372022-05-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/max-healthcare-institute-q4-fy2022-consolidated-pat-slips-qoq-to-rs-12373-cr-123362022-05-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/pfizer-offers-patent-protected-medicines-on-not-for-profit-to-45-low-income-countries-123352022-05-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/sputnik-v-demonstrates-strong-protection-against-omicron-variant-123342022-05-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/thyrocare-launches-its-regional-processing-lab-in-nagpur-on-world-thyroid-day-123332022-05-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/piramal-pharma-solutions-upgrades-pithampur-site-123322022-05-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/fitelo-unveils-new-branding-after-pre-series-a-fund-raise-123312022-05-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/enpicom-launches-versatile-display-data-analysis-solution-to-accelerate-antibody-selection-123302022-05-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/european-commission-approves-keytruda-plus-chemotherapy-as-neoadjuvant-treatment-for-breast-cancer-123292022-05-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/lonza-partners-with-israel-biotech-fund-to-support-biologics-and-small-molecules-development-123282022-05-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/cipla-scored-highest-among-pharma-companies-in-crisils-sustainability-rating-2022-123272022-05-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/borrena-approval-strengthens-pfizer-position-in-china-nsclc-market-globaldata-123262022-05-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/ipca-laboratories-posts-rs-13023-crores-consolidated-profit-in-q4fy22-123382022-05-25T00:00:00+05:30always0.9